Literature DB >> 23580615

Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Fabian Stavenuiter1, Andrew J Gale, Mary J Heeb.   

Abstract

Protein S (PS) is a multifunctional plasma protein of the hemostatic and inflammatory pathways, although mechanisms for its regulation are poorly understood. Since certain plasma proteins are regulated through extracellular phosphorylation, we investigated whether the anticoagulant activity of PS is regulated through phosphorylation by platelet-secreted kinases. PS was phosphorylated on exposure to activated platelets or their releasates, as judged by immunoblotting for phospho-amino acids and PS. PS phosphorylation was reduced by specific inhibitors of casein kinase 1 (CK1) and casein kinase 2 (CK2) (10 μM D4476, 100 μM CK2-inhibitory peptide YNLKSKSSEDIDESS). Involvement of CKs in PS phosphorylation was confirmed using purified CK1/CK2. Phosphorylation of PS by purified CK1 did not affect its activated protein C (APC) cofactor activity in activated partial thromboplastin time assays in PS-depleted plasma. However, phosphorylation of PS by CK2 or by CK1/CK2 increased PS cofactor activity ∼1.5-fold (158.7±4.8%, P<0.01) or ∼2-fold (191.5±6.4%, P<0.0001), respectively. The APC cofactor activity of PS in PS-depleted plasma exposed to platelet-secreted kinases was enhanced, while CK2 but not CK1 inhibitors reduced APC cofactor activity. Mass spectrometry revealed a phosphorylated CK2 site at Thr37 within the N-terminal Gla-domain. Thus, platelet-mediated extracellular phosphorylation of PS is a potential mechanism by which its activity is regulated.

Entities:  

Keywords:  blood coagulation regulation; vitamin K-dependent protein

Mesh:

Substances:

Year:  2013        PMID: 23580615      PMCID: PMC3688756          DOI: 10.1096/fj.12-225961

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  43 in total

Review 1.  One-thousand-and-one substrates of protein kinase CK2?

Authors:  Flavio Meggio; Lorenzo A Pinna
Journal:  FASEB J       Date:  2003-03       Impact factor: 5.191

2.  Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals.

Authors:  M J Heeb; R R Koenen; J A Fernández; T M Hackeng
Journal:  J Thromb Haemost       Date:  2004-10       Impact factor: 5.824

3.  Cleavage of protein S by a platelet membrane protease.

Authors:  C A Mitchell; H H Salem
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Phosphorylation of complement factor C3 in vivo.

Authors:  S C Martin
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

5.  Gamma-carboxylated isoforms of recombinant human protein S with different biologic properties.

Authors:  B W Grinnell; J D Walls; C Marks; A L Glasebrook; D T Berg; S B Yan; N U Bang
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

6.  Assembly of protein S and C4b-binding protein on membranes.

Authors:  R Schwalbe; B Dahlbäck; A Hillarp; G Nelsestuen
Journal:  J Biol Chem       Date:  1990-09-25       Impact factor: 5.157

7.  Plasma protein S deficiency in familial thrombotic disease.

Authors:  H P Schwarz; M Fischer; P Hopmeier; M A Batard; J H Griffin
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

8.  Cloning and characterization of human liver cDNA encoding a protein S precursor.

Authors:  J Hoskins; D K Norman; R J Beckmann; G L Long
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Identification and quantitation of protein S in human platelets.

Authors:  H P Schwarz; M J Heeb; J D Wencel-Drake; J H Griffin
Journal:  Blood       Date:  1985-12       Impact factor: 22.113

10.  Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity.

Authors:  Blandine Mille-Baker; Suely M Rezende; Rachel E Simmonds; Philip J Mason; David A Lane; Michael A Laffan
Journal:  Blood       Date:  2002-10-10       Impact factor: 22.113

View more
  8 in total

Review 1.  Extracellular Protein Phosphorylation, the Neglected Side of the Modification.

Authors:  Eva Klement; Katalin F Medzihradszky
Journal:  Mol Cell Proteomics       Date:  2016-11-10       Impact factor: 5.911

2.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

3.  Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.

Authors:  Mary J Heeb; Rolf M Mesters; José A Fernández; Tilman M Hackeng; Ryon K Nakasone; John H Griffin
Journal:  Thromb Haemost       Date:  2013-05-23       Impact factor: 5.249

4.  In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion.

Authors:  Qi Da; Hyojeong Han; Christian Valladolid; María Fernández; Tanvir Khatlani; Subhashree Pradhan; Jennifer Nolasco; Risë K Matsunami; David A Engler; Miguel A Cruz; K Vinod Vijayan
Journal:  J Thromb Haemost       Date:  2019-04-05       Impact factor: 5.824

Review 5.  The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis.

Authors:  Uwe Knippschild; Marc Krüger; Julia Richter; Pengfei Xu; Balbina García-Reyes; Christian Peifer; Jakob Halekotte; Vasiliy Bakulev; Joachim Bischof
Journal:  Front Oncol       Date:  2014-05-19       Impact factor: 6.244

6.  Phosphorylated fibronectin enhances cell attachment and upregulates mechanical cell functions.

Authors:  Garif Yalak; Jau-Ye Shiu; Ingmar Schoen; Maria Mitsi; Viola Vogel
Journal:  PLoS One       Date:  2019-07-10       Impact factor: 3.240

Review 7.  The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.

Authors:  Oskar Eriksson; Camilla Mohlin; Bo Nilsson; Kristina N Ekdahl
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

8.  The secreted tyrosine kinase VLK is essential for normal platelet activation and thrombus formation.

Authors:  Leila Revollo; Glenn Merrill-Skoloff; Karen De Ceunynck; James R Dilks; Shihui Guo; Mattia R Bordoli; Christian G Peters; Leila Noetzli; Andreia Ionescu; Vicki Rosen; Joseph E Italiano; Malcolm Whitman; Robert Flaumenhaft
Journal:  Blood       Date:  2022-01-06       Impact factor: 25.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.